Preliminary population pharmacokinetic (popPK) co-variates and exposure response (ER) assessment of QT for RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase Meeting Abstract
| Authors: | Lee, E.; Yap, T. A.; Fontana, E.; Rosen, E.; Spigel, D.; Lheureux, S.; Mettu, N. B.; Carter, L.; Plummer, R.; Patel, S.; McDougall, R.; Papp, R.; May, S.; Nejad, P.; Ulanet, D.; Wainszelbaum, M.; Manley, P.; Koehler, M.; Fretland, A. J.; Højgaard, M. |
| Abstract Title: | Preliminary population pharmacokinetic (popPK) co-variates and exposure response (ER) assessment of QT for RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase |
| Meeting Title: | ESMO Targeted Anticancer Therapies Congress (TAT) |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Mar 7-8 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-03-01 |
| Start Page: | S5 |
| End Page: | S6 |
| Language: | English |
| ACCESSION: | WOS:000767330600010 |
| DOI: | 10.1016/j.annonc.2022.01.072 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9P -- Source: Wos |
